Kazia Therapeutics Announces $2.0 Million Registered Direct Offering
Hand-out
Press Releases
January 10, 2025

Kazia Therapeutics Announces $2.0 Million Registered Direct Offering

SYDNEY, Jan. 10, 2025 /PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA) ("Kazia" or the "Company"), an oncology-focused drug development company, today announced that it has entered into a definitive agreement

bradford

The Bradford Era

Local & Social